Wednesday, June 13, 2012

NIH Invites Commercialization

NIH’s National Cancer Institute and the National Library of Medicine posted a Funding Opportunity Announcement (FOA) on June 5th. The FOA invites SBIR applications that propose to develop and disseminate evidence-based HIT products with the potential to prevent or reduce the risk of cancer, provide for patient-provider communication, and/or improve disease outcomes.

With the rapid evolution of health IT devices, standards, and platforms, there is an urgent need to translate the behavioral and communication science evidence-based to prevent and control cancer. The objective is to develop health IT tools and applications that are compatible with these emerging platforms for consumer and clinical health.

The small business must have received a prior Phase I award or may apply for a Fast-track (Phase 1/Phase II) under this FOA. The purpose of this FOA is to make it possible to transition SBIR-funded projects to the commercialization stage. This FOA is expected to promote partnerships between small and large businesses or health-related organizations that have the capacity to fully commercialize and disseminate the product.

Proposed projects must be designed for consumers, patients, health providers, and/or caregivers. The technologies must be able to improve health-related behaviors, patient-physician communication, patient engagement, and care coordination.

The funding is not to be more than $1,000,000 for Phase II awards or $1,150,000 for Fast-Track (Phase I plus Phase II) awards. The funding is expected to lead to products that can be integrated into existing EMR and PHR systems, mobile, and other emerging technology platforms that are suitable for a variety of clinical and home-based settings.

A Letter of Intent (LOI) is not required but if the LOI is submitted, it must be done 30 days before submission of the proposal. Submission dates are at various times throughout the year in April, August, and December.

The funding title is “Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers” (SBIR) (R44). To view the FOA go to For more scientific details, email Patricia Weber PhD at